The Loss of ATRX Promotes Susceptibility to KRAS-Mediated Pancreatic Disease

被引：0
作者：
Young, C. [1 ]
Howlett, C. [2 ]
Pin, C. [1 ]
机构：
[1] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, Childrens Hlth Res Inst, London, ON, Canada
[2] Univ Western Ontario, Schulich Sch Med & Dent, Dept Pathol & Lab Med, London, ON, Canada
来源：
PANCREAS | 2016年 / 45卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1549 / 1549
页数：1
相关论文
共 50 条
  • [41] Exploring the role of mutant Kras-mediated inflammation in endometriosis development using murine models
    Wu, Shin-Ting
    Tsai, Eing-Mei
    Suen, Jau-Ling
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1611 - 1611
  • [42] Carnosine inhibits KRas-mediated HCT 116 proliferation by affecting ATP and ROS production
    Iannella, M. L.
    Nocella, F.
    Iovine, B.
    Schettini, V.
    Bevilacqua, M. A.
    FEBS JOURNAL, 2011, 278 : 243 - 243
  • [43] Role Of Nicotine And Alpha 7 Nicotinic Acetylcholine Receptors In Kras-Mediated Lung Cancer
    Torres-Gonzalez, E.
    Ritzenthaler, J. D.
    Roman, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis
    Katarzyna Bogucka
    Federico Marini
    Sebastian Rosigkeit
    Janine Schloeder
    Helmut Jonuleit
    Kerstin David
    Margarita Schlackow
    Krishnaraj Rajalingam
    Cancer Gene Therapy, 2021, 28 : 359 - 374
  • [45] KRAS-mediated therapeutic resistance abrogates immunogenic cell death in colorectal cancer cells
    Wang, Yi-Jun
    Chen, Dongshi
    Tong, Jingshan
    Yu, Jian
    Bardelli, Alberto
    Zhang, Lin
    CANCER RESEARCH, 2017, 77
  • [46] Jorunnamycin A induces apoptosis in pancreatic ductal adenocarcinoma cells, spheroids, and patient-derived organoids by modulating KRAS-mediated survival pathways
    Khine, Hnin Ei Ei
    Suriya, Utid
    Rungrotmongkol, Thanyada
    Chamni, Supakarn
    Lu, Yanxi
    Benard, Alan
    Lan, Bin
    Mukhopadhyay, Debabrata
    Chang, David
    Biankin, Andrew
    Schneider-Stock, Regine
    Gruetzmann, Robert
    Sungthong, Rungroch
    Pilarsky, Christian
    Chaotham, Chatchai
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [47] ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis
    Bogucka, Katarzyna
    Marini, Federico
    Rosigkeit, Sebastian
    Schloeder, Janine
    Jonuleit, Helmut
    David, Kerstin
    Schlackow, Margarita
    Rajalingam, Krishnaraj
    CANCER GENE THERAPY, 2021, 28 (05) : 359 - 374
  • [48] G9a Responds to KRAS-Mediated Replication Stress by Increased Origin Licensing
    Thomas, Anju
    De Assuncao, Thiago Milech
    Lomberk, Gwen
    FASEB JOURNAL, 2022, 36
  • [49] Loss of ATRX expression in two metachronous pancreatic neuroendocrine neoplasms
    Kyrialcopoulos, G.
    Vaslamatzis, M.
    Kazamias, G.
    Chatzimarinaki, A.
    Alevizopoulos, N.
    Argyrakos, T.
    VIRCHOWS ARCHIV, 2016, 469 : S254 - S254
  • [50] Correction: ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis
    Katarzyna Bogucka
    Federico Marini
    Sebastian Rosigkeit
    Janine Schloeder
    Helmut Jonuleit
    Kerstin David
    Margarita Schlackow
    Krishnaraj Rajalingam
    Cancer Gene Therapy, 2021, 28 (5) : 543 - 543
12345